MRC Dementias Platform
MRC 痴呆症平台
基本信息
- 批准号:MR/L015382/1
- 负责人:
- 金额:$ 583.28万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2014
- 资助国家:英国
- 起止时间:2014 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Dementia is one of the biggest health issues that we face and is a major concern for governments around the world. Recent studies have shown that the disease processes which underlie dementia begin in middle age if not before. This suggests that it is better to develop treatments that can be used long before dementia begins to affect daily life. However, identifying these early changes is very difficult.To make detecting early changes easier, we want to create a 'one-stop-shop' for dementia researchers. We think this will help in several ways:1. It will bring scientists and industry together in partnership. This will direct our scientific efforts in ways that will help develop new treatments more efficiently. 2. It will reduce the risk of failure. A major problem in studying the early stages of dementia is finding the right people to study. It's too late if a person has dementia and it's a waste of time if they won't ever get it. To overcome this problem we will measure in detail large numbers of apparently healthy people to identify those who are showing signs of early change. 3. It will enable quicker discovery. We will bring together and share results and insights from all the major dementia related studies in the UK so that we know have a better idea of where to put our effort. For example, we will be able to rapidly identify target mechanisms in, for example, a cohort of older people with many dementia cases, and see if we find the same mechanisms operating in younger persons with early changes found in a newly recruited cohort.Combining all the information available to us in order to achieve these goals is not easy and so we will develop a powerful computing and information integration infrastructure to ensure that data and the ability to analyse it is available and accessible to a wide range of scientists representing many specialist disciplines.This project raises some difficult ethical issues. For example, what should you tell someone if they show early changes? However, these issues have to be faced if we are going to solve the dementia problem.Using these methods we think that the impact of dementia can be much reduced. Even if we are unable to stop the underlying mechanisms that produce dementia completely, by finding ways of slowing them down, and by applying these treatments as early as possible, it may be that most of us need never actually suffer the indignity of dementia, even if our 'mental arithmetic' is not what it once was.
痴呆症是我们面临的最大健康问题之一,也是世界各国政府的主要担忧。最近的研究表明,痴呆症的基础疾病过程即使不是在中年之前,也是在中年开始开始的。这表明,最好是在痴呆症开始影响日常生活之前很久就开发出可以使用的治疗方法。然而,识别这些早期变化是非常困难的。为了使检测早期变化更容易,我们想为痴呆症研究人员创建一个“一站式”。我们认为这将在几个方面有所帮助:1。它将使科学家和工业界结成伙伴关系。这将指导我们的科学努力,有助于更有效地开发新的治疗方法。2.这将降低失败的风险。研究痴呆症早期阶段的一个主要问题是找到合适的研究对象。如果一个人患有痴呆症,那就太晚了,如果他们永远不会得到它,那就是浪费时间。为了克服这个问题,我们将详细测量大量表面上健康的人,以识别那些显示出早期变化迹象的人。3.这将使更快的发现。我们将汇集并分享来自英国所有主要痴呆症相关研究的结果和见解,以便我们知道更好地了解我们的努力方向。例如,我们将能够快速识别目标机制,例如,一组患有许多痴呆症的老年人,看看我们是否在年轻人中发现了同样的机制,并在新招募的队列中发现了早期变化。为了实现这些目标,将我们现有的所有信息结合起来并不容易,因此我们将开发一个强大的计算和信息集成基础设施,以确保代表许多专业学科的广泛科学家都可以获得数据和分析数据的能力。这个项目提出了一些棘手的伦理问题。例如,你应该告诉别人,如果他们显示早期的变化?然而,如果我们要解决痴呆症问题,就必须面对这些问题。我们认为,使用这些方法可以大大减少痴呆症的影响。即使我们无法完全阻止产生痴呆症的潜在机制,通过找到减缓它们的方法,并尽早应用这些治疗方法,我们中的大多数人可能永远不需要真正遭受痴呆症的侮辱,即使我们的“心算”不是曾经的那样。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Gallacher其他文献
Nexus between residential air pollution and physiological stress is moderated by greenness
绿色缓和了住宅空气污染与生理压力之间的关系
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
K. Lai;Sarika Kumari;John Gallacher;C. Webster;C. Sarkar - 通讯作者:
C. Sarkar
Joakim Dillner: Methods in Biobanking
- DOI:
10.1007/s00439-011-0979-8 - 发表时间:
2011-03-18 - 期刊:
- 影响因子:3.600
- 作者:
John Gallacher - 通讯作者:
John Gallacher
John Gallacher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Gallacher', 18)}}的其他基金
MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine
MICA:英国痴呆症平台 2 - 综合痴呆症实验医学
- 批准号:
MR/T033371/1 - 财政年份:2021
- 资助金额:
$ 583.28万 - 项目类别:
Research Grant
UKDP: Integrated DEmentiA research environment (IDEA)
UKDP:综合痴呆症研究环境 (IDEA)
- 批准号:
MR/M009076/1 - 财政年份:2015
- 资助金额:
$ 583.28万 - 项目类别:
Research Grant
相似海外基金
A State-of-the-Art Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Alzheimer's Disease and Related Dementias
最先进的自动语音识别和对话平台,为阿尔茨海默病和相关痴呆症患者提供社交辅助机器人
- 批准号:
10699887 - 财政年份:2023
- 资助金额:
$ 583.28万 - 项目类别:
An Informatics Platform for Objectively Quantifying Electric Power Wheelchair Usage for those with Alzheimer's Disease, Alzheimer's Disease Related Dementias, and Cognitive Impairments
用于客观量化阿尔茨海默病、阿尔茨海默病相关痴呆症和认知障碍患者电动轮椅使用情况的信息学平台
- 批准号:
10457478 - 财政年份:2021
- 资助金额:
$ 583.28万 - 项目类别:
An Informatics Platform for Objectively Quantifying Electric Power Wheelchair Usage for those with Alzheimer's Disease, Alzheimer's Disease Related Dementias, and Cognitive Impairments
用于客观量化阿尔茨海默病、阿尔茨海默病相关痴呆症和认知障碍患者电动轮椅使用情况的信息学平台
- 批准号:
10325101 - 财政年份:2021
- 资助金额:
$ 583.28万 - 项目类别:
MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine
MICA:英国痴呆症平台 2 - 综合痴呆症实验医学
- 批准号:
MR/T033371/1 - 财政年份:2021
- 资助金额:
$ 583.28万 - 项目类别:
Research Grant
Care4AD: A Comprehensive Care Coordination and Management Platform for Alzheimer Disease and Related Dementias
Care4AD:阿尔茨海默病和相关痴呆症的综合护理协调和管理平台
- 批准号:
10810548 - 财政年份:2020
- 资助金额:
$ 583.28万 - 项目类别:
Care4AD: A Comprehensive Care Coordination and Management Platform for Alzheimer Disease and Related Dementias
Care4AD:阿尔茨海默病和相关痴呆症的综合护理协调和管理平台
- 批准号:
10412144 - 财政年份:2020
- 资助金额:
$ 583.28万 - 项目类别:
Care4AD: A Comprehensive Care Coordination and Management Platform for Alzheimer Disease and Related Dementias
Care4AD:阿尔茨海默病和相关痴呆症的综合护理协调和管理平台
- 批准号:
10404752 - 财政年份:2020
- 资助金额:
$ 583.28万 - 项目类别:
Care4AD: A Comprehensive Care Coordination and Management Platform for Alzheimer Disease and Related Dementias
Care4AD:阿尔茨海默病和相关痴呆症的综合护理协调和管理平台
- 批准号:
10009667 - 财政年份:2020
- 资助金额:
$ 583.28万 - 项目类别:
Dementias Platform UK MR-PET Partnership
英国痴呆症平台 MR-PET 合作伙伴关系
- 批准号:
MR/N025792/1 - 财政年份:2016
- 资助金额:
$ 583.28万 - 项目类别:
Research Grant
Dementias Platform UK Stem Cell Partnership
痴呆症平台英国干细胞合作伙伴关系
- 批准号:
MR/N013255/1 - 财政年份:2016
- 资助金额:
$ 583.28万 - 项目类别:
Research Grant














{{item.name}}会员




